AbbVie-Allergan merger will impact Irish units

With EU regulatory approval in the bag and US regulatory scrutiny expected to clear in the coming weeks, the €55bn AbbVie and Allergan merger should start in earnest in February or March.

AbbVie, although headquartered in the US, has manufacturing sites in Cork and Sligo, while Allergan has its headquarters in Dublin and main manufacturing base in Westport.